Literature DB >> 12063170

Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.

Chia-Ping Huang Yang1, Susan Band Horwitz.   

Abstract

Nanomolar concentrations of Taxol, and other antimitotic agents that interact with microtubules, mediate serine phosphorylation of the 66-kDa Shc isoform (p66shc) in A549 human lung carcinoma cells, 9-18 h after drug treatment. This event coincides with the release of PARP cleavage fragments that are early indicators of apoptosis. Taxol-induced serine phosphorylation of p66shc results from a MEK-independent signaling pathway that is activated in A549 cells that have a prolonged or abnormal mitotic phase of the cell cycle [Cancer Res. 60 (2000) 5171]. In contrast, in murine macrophage RAW 264.7 cells, micromolar concentrations of Taxol but not other microtubule-interacting agents induced serine phosphorylation of p66shc that correlated with the phosphorylation of Raf-1 and extracellular signal-regulated kinase (ERK1/2), within 15-30 min after Taxol treatment. This event also was induced by lipopolysaccharide (LPS). The MEK-inhibitor, U0126, that specifically inhibits the activation of ERK also blocked the phosphorylation of p66shc and Raf-1, suggesting that these processes were MEK-dependent, quite different from that which was observed in A549 cells. Taxol also induced phosphorylation of p38 and JNK MAP kinases within 8-15 min after drug treatment. It is known that Taxol, but not other microtubule-interacting agents, induces the production of cytokines, such as tumor necrosis factor alpha (TNF-alpha) in mouse macrophages. The time course of Taxol-induced TNF-alpha expression coincides with that of Taxol-induced p66shc phosphorylation, and U0126 inhibits significantly Taxol-induced TNF-alpha expression in RAW 264.7 cells. Our data indicate that the Taxol-induced serine phosphorylation of p66shc in RAW 264.7 cells is microtubule-independent and may be related to increased TNF-alpha expression after Taxol and LPS treatment. It is concluded that the mechanisms involved in Taxol-induced p66shc phosphorylation are distinct in A549 and RAW 264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063170     DOI: 10.1016/s0167-4889(02)00200-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells.

Authors:  Annalisa Natalicchio; Federica Tortosa; Rossella Labarbuta; Giuseppina Biondi; Nicola Marrano; Emanuele Carchia; Anna Leonardini; Angelo Cignarelli; Marco Bugliani; Piero Marchetti; Gian Paolo Fadini; Marco Giorgio; Angelo Avogaro; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2015-03-26       Impact factor: 10.122

3.  Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.

Authors:  Mohamed Naguib; Jijun J Xu; Philippe Diaz; David L Brown; David Cogdell; Bihua Bie; Jianhua Hu; Suzanne Craig; Walter N Hittelman
Journal:  Anesth Analg       Date:  2012-03-05       Impact factor: 5.108

4.  Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans.

Authors:  Matt K Lee; Gloria S Pryhuber; Margaret A Schwarz; Susan M Smith; Zdena Pavlova; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2005-03-18       Impact factor: 21.405

Review 5.  p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.

Authors:  Mythilypriya Rajendran; Paul Thomes; Li Zhang; Suresh Veeramani; Ming-Fong Lin
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

6.  Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.

Authors:  S Veeramani; T-C Yuan; F-F Lin; M-F Lin
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

7.  Diallyl trisulfide-induced prostate cancer cell death is associated with Akt/PKB dephosphorylation mediated by P-p66shc.

Authors:  Andzelika Borkowska; Alicja Sielicka-Dudzin; Anna Herman-Antosiewicz; Michal Wozniak; Donatella Fedeli; Giancarlo Falcioni; Jedrzej Antosiewicz
Journal:  Eur J Nutr       Date:  2011-10-22       Impact factor: 5.614

Review 8.  p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.

Authors:  Sahar S Bhat; Deepak Anand; Firdous A Khanday
Journal:  Mol Cancer       Date:  2015-04-08       Impact factor: 27.401

9.  Reversible blockade of complex I or inhibition of PKCβ reduces activation and mitochondria translocation of p66Shc to preserve cardiac function after ischemia.

Authors:  Meiying Yang; David F Stowe; Kenechukwu B Udoh; James S Heisner; Amadou K S Camara
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

10.  Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells.

Authors:  A Conte; C Procaccini; P Iannelli; A Kisslinger; F De Amicis; G M Pierantoni; F P Mancini; G Matarese; D Tramontano
Journal:  Transl Med UniSa       Date:  2016-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.